Research of Metabolic Syndrome X has been linked to Obesity, Diabetes Mellitus, Insulin Resistance, Cardiovascular Diseases, Hypertensive Disease. The study of Metabolic Syndrome X has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Metabolic Syndrome X include Pathogenesis, Secretion, Aging, Insulin Secretion, Excretion. These pathways complement our catalog of research reagents for the study of Metabolic Syndrome X including antibodies and ELISA kits against INS, CRP, ADIPOQ, LEP, TNF.
Metabolic Syndrome X Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Metabolic Syndrome X below!
For more information on how to use Laverne, please read the How to Guide.
We have 2978 products for the study of Metabolic Syndrome X that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Metabolic Syndrome X is also known as metabolic syndrome x, abdominal obesity-metabolic syndrome, abdominal obesity metabolic syndrome, metabolic syndrome x (disorder), dysmetabolic syndrome x, aoms1.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.